TUBG2
Basic information
Region (hg38): 17:42659284-42667006
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUBG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 2 |
Variants in TUBG2
This is a list of pathogenic ClinVar variants found in the TUBG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-42659528-C-G | not specified | Uncertain significance (Jul 12, 2022) | ||
17-42659901-A-G | Benign (Aug 15, 2018) | |||
17-42659914-G-A | not specified | Uncertain significance (May 04, 2023) | ||
17-42663022-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
17-42663050-C-G | not specified | Uncertain significance (Nov 19, 2022) | ||
17-42663456-A-G | not specified | Uncertain significance (Jan 27, 2022) | ||
17-42663484-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
17-42665545-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
17-42665712-T-C | not specified | Uncertain significance (Apr 04, 2024) | ||
17-42665723-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
17-42666129-C-T | not specified | Uncertain significance (Aug 14, 2023) | ||
17-42666165-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
17-42666180-A-T | not specified | Uncertain significance (Nov 17, 2022) | ||
17-42666375-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
17-42666386-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
17-42666670-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
17-42666681-A-G | Benign (Aug 03, 2020) | |||
17-42666739-T-C | not specified | Uncertain significance (Feb 06, 2023) | ||
17-42666750-C-T | not specified | Uncertain significance (Jun 17, 2022) | ||
17-42666775-T-C | not specified | Uncertain significance (May 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TUBG2 | protein_coding | protein_coding | ENST00000251412 | 11 | 7702 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000121 | 0.990 | 125687 | 0 | 61 | 125748 | 0.000243 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.44 | 167 | 283 | 0.591 | 0.0000173 | 2966 |
Missense in Polyphen | 61 | 111.62 | 0.54652 | 1227 | ||
Synonymous | -1.18 | 133 | 117 | 1.14 | 0.00000734 | 873 |
Loss of Function | 2.30 | 12 | 24.2 | 0.496 | 0.00000129 | 247 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000390 | 0.000387 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000257 | 0.000255 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000490 | 0.000490 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Tubulin is the major constituent of microtubules. The gamma chain is found at microtubule organizing centers (MTOC) such as the spindle poles or the centrosome. Pericentriolar matrix component that regulates alpha/beta chain minus-end nucleation, centrosome duplication and spindle formation (By similarity). {ECO:0000250}.;
- Pathway
- Human papillomavirus infection - Homo sapiens (human);Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;G2/M Transition;Mitotic G2-G2/M phases;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Intolerance Scores
- loftool
- 0.479
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.76
Haploinsufficiency Scores
- pHI
- 0.201
- hipred
- Y
- hipred_score
- 0.785
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.648
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Tubg2
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- mitotic sister chromatid segregation;meiotic spindle organization;microtubule cytoskeleton organization;mitotic cell cycle;microtubule-based process;microtubule nucleation;mitotic spindle organization;cytoplasmic microtubule organization
- Cellular component
- pericentriolar material;gamma-tubulin complex;nucleus;cytoplasm;centrosome;spindle;cytosol;microtubule;spindle microtubule;cytoplasmic microtubule;microtubule cytoskeleton
- Molecular function
- GTPase activity;structural molecule activity;structural constituent of cytoskeleton;GTP binding